Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2004 Jul;30(7):1432-7.
doi: 10.1007/s00134-004-2176-x. Epub 2004 Feb 28.

Crystalloid strong ion difference determines metabolic acid-base change during acute normovolaemic haemodilution

Affiliations
Comparative Study

Crystalloid strong ion difference determines metabolic acid-base change during acute normovolaemic haemodilution

Thomas J Morgan et al. Intensive Care Med. 2004 Jul.

Abstract

Objective: To study the acid-base effects of crystalloid strong ion difference (SID) during haemodilution.

Design: Prospective in vivo study.

Setting: University laboratory.

Subjects: Anaesthetised, mechanically ventilated Sprague-Dawley rats.

Interventions: Rats were studied in seven groups of three. Each group underwent normovolaemic haemodilution with one of seven crystalloids, with SID values from 0 to 40 mEq/l. Six exchanges of 9 ml crystalloid for 3 ml blood were performed.

Measurements and main results: [Hb] fell from 142+/-17 to 44+/-10 g/l ( p<0.0001). Final plasma [lactate] was 1.1+/-0.6 mmol/l. Final standard base excess values ranged from -8 to +7 mmol/l, and were directly correlated with crystalloid SID (R(2)=0.91). By linear regression, the SID of a crystalloid balanced to maintain standard base excess=0 mmol/l was 23.7 mEq/l. Dilutions 2-5 produced similar results.

Conclusions: There is a linear relationship between crystalloid SID and post-dilutional metabolic acid-base status. The SID of a crystalloid balanced for normovolaemic haemodilution is 24 mEq/l. These principles are applicable in designing fluids for volume resuscitation, acute normovolaemic haemodilution and cardio-pulmonary bypass.

PubMed Disclaimer

References

    1. Anesth Analg. 2001 Oct;93(4):811-6 - PubMed
    1. Scand J Clin Lab Invest. 1977 Feb;37(1):15-20 - PubMed
    1. Am J Physiol. 1970 Apr;218(4):1201-7 - PubMed
    1. Anesthesiology. 1999 May;90(5):1247-9 - PubMed
    1. Anesthesiology. 2000 Nov;93(5):1170-3 - PubMed

Publication types

LinkOut - more resources